Related Experiment Videos
[Cytogenetics of recurrent acute leukemia]
1I. Laboratoire d'hématologie et de cytogénétique, Hôpital Edouard-Herriot, Lyon.
La Revue Du Praticien
|January 1, 1996
Summary
Cytogenetic abnormalities in acute leukemia are common and linked to specific subtypes and outcomes. These chromosomal changes help predict prognosis and detect disease relapse.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Context:
- Acute leukemia is characterized by non-random chromosomal abnormalities in 50-80% of patients.
- These abnormalities correlate with specific morphological and immunological findings, aiding in classification.
- Karyotype analysis in acute lymphoblastic leukemia (ALL) serves as an independent prognostic factor.
Purpose:
- To investigate the role of cytogenetic abnormalities in acute leukemia.
- To correlate chromosomal changes with clinical, morphological, and immunological features.
- To assess the prognostic and diagnostic value of cytogenetic studies in leukemia.
Summary:
- Non-random chromosomal abnormalities are prevalent in acute leukemia and associated with specific subtypes, such as t(15;17) in FAB M3 and t(1;19) in pre-B/early pre-B ALL.
- Favorable prognostic indicators include hyperdiploidy (>50 chromosomes) in ALL and inv(16) in acute myeloid leukemia (AML).
- Adverse prognostic markers include the Philadelphia chromosome or t(4;11) in ALL, and del5q or trisomy 8 in AML.
Impact:
- Cytogenetic studies are crucial for predicting patient outcomes in acute leukemia.
- These analyses are valuable tools for detecting relapse and residual disease.
- Chromosomal abnormalities identified through cytogenetics provide targets for molecular studies into leukemogenesis.